Avelo provides a non‑invasive breath aerosol collection kit, the AveloMask, that captures viruses and bacteria from the entire respiratory tract for molecular testing. The system uses a mask and buffer tube to collect, elute, and transfer pathogens to standard multiplex assays, enabling rapid diagnosis of respiratory infections. By facilitating accurate pathogen identification, Avelo aims to improve treatment decisions, expand access to testing, and reduce unnecessary antibiotic use.
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ISFounders
Product
Problem
Respiratory infections, including pneumonia and tuberculosis, pose a significant global health threat, leading to millions of deaths annually. Current diagnostic methods for these infections often involve invasive sampling techniques or lack the speed and accuracy needed for timely treatment decisions. This can result in delayed or inappropriate treatment, contributing to antibiotic overuse and increased healthcare costs.
Solution
Avelo provides a non-invasive breath sampling kit designed to improve the speed and accuracy of infectious disease diagnostics. The AveloCollect and AveloMask kits capture viral and bacterial pathogens from a patient's breath, which can then be analyzed using existing molecular tests, such as PCR. This approach simplifies sample collection, reduces the risk of errors associated with traditional methods, and enables earlier, more targeted treatment of respiratory infections. By differentiating between viral and bacterial infections, Avelo's solution also helps to combat antimicrobial resistance by reducing unnecessary antibiotic prescriptions.
Target Audience
The primary target audience includes healthcare providers in primary care settings, hospitals, and diagnostic laboratories seeking rapid and accurate diagnostic tools for respiratory infections like pneumonia and tuberculosis.
Features
- Non-invasive breath sampling using AveloCollect and AveloMask kits
- Compatibility with existing molecular diagnostic platforms, including PCR
- Capture of viral and bacterial pathogens directly from the patient's breath
- Simplified sample collection process, reducing the potential for errors
- Potential to differentiate between viral and bacterial infections, aiding in appropriate treatment decisions
- Filter inside the mask captures disease-causing viruses and bacteria from the lungs
- Filter can be quickly and easily transferred into the buffer tube for molecular testing